Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors (8-35 Years): The Role of Cancer Treatment and Repeated Anesthesia

NCT06227962 is registered in ClinicalTrials.gov with Amsterdam University Medical Center as lead sponsor.

NCT NCT06227962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06227962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors (8-35 Years): The Role of Cancer Treatment and Repeated Anesthesia
Lead sponsor
Amsterdam University Medical Center
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 26, 2023
Completion date
March 31, 2028
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health-related behavior, neurocognitive dysfunction, retinoblastoma